LC
IMGN

Lindbrook Capital’s Immunogen Inc IMGN Stock Holding History

Lindbrook Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-625
Closed -$18.5K – 2780
2023
Q4 		$18.5K Buy
625
+416
+199% +$8.28K ﹤0.01% 1215
2023
Q3 		$3.32K Buy
209
+15
+8% +$249 ﹤0.01% 1946
2023
Q2 		$3.66K Buy
+194
New +$2.29K ﹤0.01% 1938
2023
Q1 		– Sell
-297
Closed -$1.47K – 2945
2022
Q4 		$1.47K Buy
297
+239
+412% +$1.3K ﹤0.01% 2363
2022
Q3 		$0 Buy
+58
New +$306 ﹤0.01% 2983

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's IMGN Position: Q1 2024 in Review

Lindbrook Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 625 shares — an estimated $18.5K sold.

Lindbrook Capital first reported a position in IMGN in Q3 2022 and held it in 5 quarters. The position peaked at $18.5K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Lindbrook Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Lindbrook Capital sold 625 Immunogen Inc shares in Q1 2024, an estimated $18.5K.
  • Lindbrook Capital first reported a position in Immunogen Inc in Q3 2022 and held it in 5 quarters.
  • Lindbrook Capital's Immunogen Inc position peaked at $18.5K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.